Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Find out which option tends to yield steadier income—index funds or bonds—and how to blend them for reliability and growth.
24,934 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Broadcom's AI outlook miss triggered a pronounced one-day pullback, signaling investor caution around AI-driven growt...
A New World screwworm outbreak has been confirmed in Texas, raising the stakes for cattle operations and farm income ...
A growing clash over baseball economics enters a new phase as Trump signals support for a hard salary cap in MLB, int...
When a CEO discloses a large stock sale, markets react. This guide breaks down what sells $2.4 million international ...
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
A growing number of households are buying cold plunge tubs as a wellness trend, but experts say the benefits are mixe...
Virgin Galactic leads a broad rally in space stocks after a liquidity-boosting debt-for-equity swap. AST SpaceMobile,...
Meta Platforms faces a heavy AI investment cycle that could weigh on near-term cash flow, even as revenue climbs. Thi...
Ripple's XRPL launches an AI Starter Kit to enable autonomous AI agents to transact with XRP and RLUSD, aiming to lea...
Applied Materials is back within reach of the $500 level after a sharp June selloff, fueling renewed debate on whethe...
MercadoLibre reports 40% year-over-year growth fueled by fintech expansion and a resilient e-commerce network in Lati...